Treatment for Language Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Vanderbilt University, Nashville, TNLanguage DisorderEMT en Español - Behavioral
Eligibility
30 - 36
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new communication intervention to improve language and school readiness skills in low-income Spanish-speaking children with receptive and expressive language delays, compared to a control group.

Treatment Effectiveness

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: 5 months, 11 months, 17 months

11 months, 17 months
Number of language targets used across the English and Spanish narrative retell measures.
Unprompted Number of Different Conceptual Words across English and Spanish taken from the English and Spanish narrative retell measures.
17 months
Bilingual English-Spanish Assessment (BESA) standard score (0-100)
5 months
Number of language targets used across 2 20-minute standardized play-based language samples with a trained assessor.
Total raw score from Receptive and Expressive One-Word Picture Vocabulary Tests - Spanish Bilingual Edition (ROWPVT-SBE)
Unprompted Number of Different Conceptual Words across English and Spanish from 2 20-minute standardized play-based Language Samples with a trained assessor.
Month 17
Composite Executive Function Score

Trial Safety

Trial Design

2 Treatment Groups

Treatment
1 of 2
Control
1 of 2

Active Control

90 Total Participants · 2 Treatment Groups

Primary Treatment: Treatment · No Placebo Group · N/A

Treatment
Behavioral
ActiveComparator Group · 1 Intervention: EMT en Español · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 months, 11 months, 17 months

Who is running the clinical trial?

Institute of Education SciencesFED
6 Previous Clinical Trials
2,246 Total Patients Enrolled
Vanderbilt UniversityLead Sponsor
685 Previous Clinical Trials
6,132,722 Total Patients Enrolled
Tatiana Peredo, PhdDPrincipal InvestigatorVanderbilt University
Ann P Kaiser, PhdDPrincipal InvestigatorVanderbilt University

Eligibility Criteria

Age 30 - 36 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The child does not have any other conditions that affect their ability to learn and communicate, such as autism, Down syndrome, cerebral palsy, blindness, or deafness.

Frequently Asked Questions

Has recruitment commenced for this research endeavor?

"According to the clinicaltrial.gov website, this experiment is still seeking participants. It was initially unveiled on the 1st of December 2019 and last modified on October 17th 2022." - Anonymous Online Contributor

Unverified Answer

For whom is this research being conducted?

"This trial seeks 90 infants aged between 2.5 and 3 years old, who are displaying language delay beyond 1.5 standard deviations of the mean as measured by Preschool Language Scale- 5th edition Spanish, have cognitive skills close to the mean according to Leiter-R test results, do not possess any other disabilities such as ASD or Down Syndrome and whose family is economically disadvantaged (income up to two times federal poverty level)." - Anonymous Online Contributor

Unverified Answer

Are elderly individuals being incorporated into this clinical investigation?

"According to the established parameters, potential participants must be between 30 and 36 months old in order to join this clinical trial." - Anonymous Online Contributor

Unverified Answer

How many individuals are actively participating in this investigation?

"Affirmative. According to the records posted on clinicaltrials.gov, this medical trial is presently recruiting participants; it was first published in December of 2019 and last updated October 17th 2022. Ninety individuals are required for enrollment at a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.